Similar articles for PMID: 16550390

Year	Number of Results
1981	2
1982	4
1983	1
1984	1
1985	1
1986	2
1987	1
1988	1
1989	2
1990	3
1991	2
1992	3
1993	9
1994	2
1995	5
1996	4
1997	3
1998	3
1999	2
2000	9
2001	13
2002	20
2003	18
2004	33
2005	32
2006	26
2007	20
2008	20
2009	16
2010	18
2011	12
2012	18
2013	7
2014	14
2015	10
2016	11
2017	7
2018	7
2019	6
2020	6
2021	2
2022	4
2023	1
2024	0

1

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.

Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR; Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP. Peñalver FJ, et al. Ann Hematol. 2006 Jun;85(6):400-6. doi: 10.1007/s00277-005-0073-1. Epub 2006 Mar 21. Ann Hematol. 2006. PMID: 16550390

2

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.

Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC. Braendstrup P, et al. Am J Hematol. 2005 Apr;78(4):275-80. doi: 10.1002/ajh.20276. Am J Hematol. 2005. PMID: 15795920 Free article.

3

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.

Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB. Cooper N, et al. Br J Haematol. 2004 Apr;125(2):232-9. doi: 10.1111/j.1365-2141.2004.04889.x. Br J Haematol. 2004. PMID: 15059147 Free article.

4

Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.

Schweizer C, Reu FJ, Ho AD, Hensel M. Schweizer C, et al. Ann Hematol. 2007 Oct;86(10):711-7. doi: 10.1007/s00277-007-0335-1. Epub 2007 Jul 11. Ann Hematol. 2007. PMID: 17622529

5

Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.

Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A. Dierickx D, et al. J Intern Med. 2009 Nov;266(5):484-91. doi: 10.1111/j.1365-2796.2009.02126.x. Epub 2009 Apr 27. J Intern Med. 2009. PMID: 19549092 Free article.

6

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.

Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR; Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA. Peñalver FJ, et al. Ann Hematol. 2010 Nov;89(11):1073-80. doi: 10.1007/s00277-010-0997-y. Epub 2010 Jun 5. Ann Hematol. 2010. PMID: 20526716

7

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.

Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH. Koulova L, et al. Am J Hematol. 2005 Jan;78(1):49-54. doi: 10.1002/ajh.20243. Am J Hematol. 2005. PMID: 15609292 Free article.

8

Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.

Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M; Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto. Vianelli N, et al. Haematologica. 2005 Jan;90(1):72-7. Haematologica. 2005. PMID: 15642672

9

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.

Medeot M, Zaja F, Vianelli N, Battista M, Baccarani M, Patriarca F, Soldano F, Isola M, De Luca S, Fanin R. Medeot M, et al. Eur J Haematol. 2008 Sep;81(3):165-9. doi: 10.1111/j.1600-0609.2008.01100.x. Epub 2008 May 27. Eur J Haematol. 2008. PMID: 18510702

10

Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).

Alasfoor K, Alrasheed M, Alsayegh F, Mousa SA. Alasfoor K, et al. Ann Hematol. 2009 Mar;88(3):239-43. doi: 10.1007/s00277-008-0574-9. Epub 2008 Aug 15. Ann Hematol. 2009. PMID: 18704420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

350 results

Results by year